FDAnews Drug Daily Bulletin

GLAXOSMITHKLINE WILL BEGIN USING TRACKING DEVICE ON SOME DRUG BOTTLES TO PREVENT COUNTERFEITING

March 30, 2006
A A

GlaxoSmithKline (GSK), the world's second largest pharmaceutical company, has announced that, by April, radio frequency identification devices (RFIDs) will be attached to bottles of its antiretroviral drug Trizivir that are shipped to the United States. GSK is taking this step as part of a pilot project designed in partnership with IBM to prevent counterfeiting of the drug. Pfizer has been using similar technology to tag bottles of Viagra since January.

News Inferno (http://www.newsinferno.com/archives/1024)